title: [Travel advice and vaccinations in patients with chronic inflammatory diseases: the earlier, the better].
abstract: The number of patients with chronic inflammatory diseases who have been travelling to the tropics or subtropics has been rising. Use of immunomodulating drugs increases the risk for infectious diseases and may reduce seroprotection rates following vaccination. In addition, live vaccines, such as the yellow fever vaccine, are contra-indicated. Patients and their physicians are not always aware of the consequences of the use of immunomodulating drugs for travel and this may lead to undesirable situations, including last-minute cancellation of the trip. Informing and vaccinating patients early after the diagnosis of the inflammatory disease may prevent these undesirable situations.
authors.affiliation: Radboudumc, afd. Interne Geneeskunde, Nijmegen.
authors.forename: Quirijn
authors.initials: Q
authors.lastname: de Mast
authors.forename: Monique
authors.initials: M
authors.lastname: Keuter
authors.forename: Pieter P A M
authors.initials: PP
authors.lastname: van Thiel
authors.forename: André J A M
authors.initials: AJ
authors.lastname: van der Ven
mesh_terms: D000328:Adult; D000075202:Contraindications; D005260:Female; D006801:Humans; D016867:Immunocompromised Host; D018836:Inflammation Mediators / Q000008:administration & dosage / Q000009:adverse effects; D008297:Male; D014195:Travel; D014611:Vaccination; D014613:Vaccines, Attenuated / Q000008:administration & dosage / Q000009:adverse effects; D022341:Yellow Fever Vaccine / Q000008:administration & dosage / Q000009:adverse effects; D055815:Young Adult
chemical_list: D018836:Inflammation Mediators; D014613:Vaccines, Attenuated; D022341:Yellow Fever Vaccine